Main > ONCOLOGY (**) > Bone MET>from Solid Tumors *** > USA. A. DenosuMAb



USA. A. DenosuMAb's subsections
(*) CA Approval Date: ?
(*) CN Approval Date: 2020. 11.19
(*) EU Approval Date: 2011. 07.15
(*) USA Approval Date: ?
Company
Company Licensee (CN)
Patent>Assignee; Claims; No.; Etc
Patent>Total USA No.: 23
Patent>UpDate: 2021. 02.09
TradeMark
TradeMark Web-Site
Used to Prevent>

USA. A. DenosuMAb's products
This section has no products